The roles of vasohibin and its family members: Beyond angiogenesis modulators

References

• Kerbel RS. Vasohibin: the feedback on a new inhibitor of angiogenesis. J Clin Invest. 2004;114: 884–886. doi:10.1172/JCI23153.
   PubMed Web of Science ®Google Scholar
• Sonoda H, Ohta H, Watanabe K, Yamashita H, Kimura H, Sato Y. Multiple processing forms and their biological activities of novel angiogenesis inhibitor vasohibin. Biochem Biophys Res Commun. 2006; 7;342(2):640–6. doi:10.1016/j.bbrc.2006.01.185.
   PubMed Web of Science ®Google Scholar
• Takeda E, Suzuki Y, Sato Y. Age-associated down regulation of vasohibin-1 in vascular endothelial cells. Aging Cell. 2016;15(5):885–92. doi:10.1111/acel.12497.
   PubMed Web of Science ®Google Scholar
• Shimizu K, Watanabe K, Yamashita H, Abe M, Yoshimatsu H, Ohta H, Sonoda H, Sato Y. Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun. 2005;327(3):700–6. doi:10.1016/j.bbrc.2004.12.073.
   PubMed Web of Science ®Google Scholar
• Kern J, Bauer M, Rychli K, Wojta J, Ritsch A, Gastl G, Gunsilius E, Untergasser G. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Arterioscler Thromb Vasc Biol. 2008;28(3):478–84. doi:10.1161/ATVBAHA.107.160432.
   PubMed Web of Science ®Google Scholar
• Hegde RS and Kang SW. The concept of translocational regulation. J Cell Biol. 2008;182:225–232. doi:10.1083/jcb.200804157.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Kobayashi M, Miyashita H, Ohta H, Sonoda H, Sato Y. Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion. J Cell Sci. 2010;123:3094–4101. doi:10.1242/jcs.067538.
   PubMed Web of Science ®Google Scholar
• Kadonosono T, Yimchuen W, Tsubaki T, Shiozawa T, Suzuki Y, Kuchimaru T, Sato Y, Kizaka -Kondoh S. Domain architecture of vasohibins required for their chaperone-dependent unconventional extracellular release. Protein Sci. 2017;26(3):452–463. doi:10.1002/pro.3089.
   PubMed Web of Science ®Google Scholar
• Shibuya T, Watanabe K, Yamashita H, Shimizu K, Miyashita H, Abe M, Moriya T, Ohta H, Sonoda H, Shimosegawa T, et al. Isolation of vasohibin-2 as a sole homologue of VEGF inducible endothelium-derived angiogenesis inhibitor vasohibin: a comparative study on their expressions. Arterioscler Thrombo Vasc Biol. 2006;26:1051–1057. doi:10.1161/01.ATV.0000216747.66660.26.
   PubMed Web of Science ®Google Scholar
• Sato Y and Sonoda H. The vasohibin family: a negative regulatory system of angiogenesis genetically programmed in endothelial cells. Arterioscler Thrombo Vasc Biol. 2007;27: 37–41. doi:10.1161/01.ATV.0000252062.48280.61.
   PubMed Web of Science ®Google Scholar
• Sato Y. The vasohibin family: A novel family for angiogenesis regulation. J Biochem. 2013;153:5–11. doi:10.1093/jb/mvs128.
   PubMed Web of Science ®Google Scholar
• Kimura H, Miyashita H, Suzuki Y, Kobayashi M, Watanabe K, Sonoda H, Ohta H, Fujiwara T, Shimosegawa T, Sato Y. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood. 2009;113: 4810–4818.doi:10.1182/blood-2008-07-170316.
   PubMed Web of Science ®Google Scholar
• Sanchez-Pulido L, Ponting CP. Vasohibins: new transglutaminase-like cysteine proteases possessing a non-canonical Cys-His-Ser catalytic triad. Bioinformatics. 2016;32(10):1441–5. doi:10.1093/bioinformatics/btv761.
   PubMed Web of Science ®Google Scholar
• Kozako T, Matsumoto N, Kuramoto Y, Sakata A, Motonagare R, Aikawa A, Imoto M, Toda A, Honda S, Shimeno H, et al. Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells. FEBS Lett. 2012;586(7):1067–72.doi:10.1016/j.febslet.2012.03.007.
   PubMed Web of Science ®Google Scholar
• Nimmagadda S, Geetha-Loganathan P, Pröls F, Scaal M, Christ B, Huang R.. Expression pattern of vasohibin during chick development. Dev Dyn. 2007;236:1358–1362. doi:10.1002/dvdy.21134.
   PubMed Web of Science ®Google Scholar
• Kishlyansky M, Vojnovic J, Roudier E, Gineste C, Decary S, Forn P, Bergeron R, Desplanches D, Birot O. Striated muscle angio-adaptation requires changes in Vasohibin-1 expression pattern. Biochem Biophys Res Commun. 2010;399:359–364. doi:10.1016/j.bbrc.2010.07.076.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y. Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis. Mol Cancer Res. 2012;10:1135–1146. doi:10.1158/1541-7786.MCR-12-0098-T.
   PubMed Web of Science ®Google Scholar
• Hosaka T, Kimura H, Heishi T, Suzuki Y, Miyashita H, Ohta H, Sonoda H, Moriya T, Suzuki S, Kondo T, et al. Vasohibin-1 expressed in endothelium of tumor vessels regulates angiogenesis. Am J Pathol. 2009;175: 430–439. doi:10.2353/ajpath.2009.080788.
   PubMed Web of Science ®Google Scholar
• Heishi T, Hosaka T, Suzuki Y, Miyashita H, Oike Y, Takahashi T, Nakamura T, Arioka S, Mitsuda Y, Takakura T, et al. Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol. 2010;176:1950–1958. doi:10.2353/ajpath.2010.090829.
   PubMed Web of Science ®Google Scholar
• Suenaga K, Kitahara S, Suzuki Y, Kobayashi M, Horie S, Sugawara J, Yaegashi N, Sato Y. Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation. Plos One. 2014;9: 1–10. doi:10.1371/journal.pone.0104728.
   Web of Science ®Google Scholar
• Miyashita H, Watanabe T, Hayashi H, Suzuki Y, Nakamura T, Ito S, Ono M, Hoshikawa Y, Okada Y, Kondo T, et al. Angiogenesis inhibitor vasohibin-1 enhances stress resistance of endothelial cells via induction of SOD2 and SIRT1. Plos One. 2012;7(10):e46459. doi:10.1371/journal.pone.0046459.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Abe M, Watanabe K, Shimizu K, Moriya T, Sato A, Satomi S, Ohta H, Sonoda H, Sato Y. Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem Biophys Res Commun. 2006;345:919–925. doi:10.1016/j.bbrc.2006.04.176.
   PubMed Web of Science ®Google Scholar
• Wakusawa R, Abe T, Sato H, Yoshida M, Kunikata H, Sato Y, Nishida K. Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes. Am J Ophthalmol. 2008;146: 235–243. doi:10.1016/j.ajo.2008.03.019.
   PubMed Web of Science ®Google Scholar
• Sato H, Abe T, Wakusawa R, Asai N, Kunikata H, Ohta H, Sonoda H, Sato Y, Nishida K. Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetologia. 2009;52:359–361. doi:10.1007/s00125-008-1229-z.
   PubMed Web of Science ®Google Scholar
• Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Yaegashi N, Sato Y.. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci. 2008;99:914–919. doi:10.1111/j.1349-7006.2008.00777.x.
   PubMed Web of Science ®Google Scholar
• Tamaki K, Moriya T, Sato Y, Ishida T, Maruo Y, Yoshinaga K, Ohuchi N, Sasano H. Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci. 2008;100: 88–94. doi:10.1111/j.1349-7006.2008.01015.x.
   PubMed Web of Science ®Google Scholar
• Tamaki K, Sasano H, Maruo Y, Takahashi Y, Miyashita M, Moriya T, Sato Y, Hirakawa H, Tamaki N, Watanabe M, et al. Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast. Cancer Sci. 2010;101:1051–1058. doi:10.1111/j.1349-7006.2009.01483.x.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kohno H, Suzuki R, Hata K, Sugie S, Niho N, Sakano K, Takahashi M, Wakabayashi K. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc (Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int J Cancer. 2006;118:25–34. doi:10.1002/ijc.21282.
   PubMed Web of Science ®Google Scholar
• Kitahara S, Suzuki Y, Morishima M, Yoshii A, Kikuta S, Shimizu K, Morikawa S, Sato Y, Ezaki T. Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. Mol Cancer. 2014;13(99):1–15. doi:10.1186/1476-4598-13-99.
   PubMed Web of Science ®Google Scholar
• Li D, Zhou K, Wang S, Shi Z, Yang Z. Recombinant adenovirus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth. Cancer Sci. 2010;101(2):448–452. doi:10.1111/j.1349-7006.2009.01388.x.
   PubMed Web of Science ®Google Scholar
• Liu S, Han B, Zhang Q, Dou J, Wang F, Lin W, Sun Y, Peng G. Vasohibin-1 suppresses colon cancer. See comment in PubMed Commons belowOncotarget. 2015;6(10):7880–98. doi: 10.18632/oncotarget.3493.
   Google Scholar
• Lu C, Han HD, Mangala LS, Ali-Fehmi R, Newton CS, Ozbun L, Armaiz-Pena GN, Hu W, Stone RL, Munkarah A, et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell. 2010;18:185–197. doi:10.1016/j.ccr.2010.06.016.
   PubMed Web of Science ®Google Scholar
• Chan MS, Wang L, Chanplakorn N, Tamaki K, Ueno T, Toi M, Loo WT, Chow LW, Suzuki T, Sasano H.. Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma–an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy. Expert Opinion Therapeutic Targets. 2012;16:69–78. doi:10.1517/14728222.2011.628938.
   PubMed Web of Science ®Google Scholar
• Wang Q, Tian X, Zhang C, Wang Q. Upregulation of vasohibin-1 expression with angiogenesis and poor prognosis of hepatocellular carcinoma after curative surgery. Med oncol. 2012;29(4):2727–2736. doi:10.1007/s12032-011-0106-7.
   PubMed Web of Science ®Google Scholar
• Kanomata N, Sato Y, Miyaji Y, Nagai A, Moriya T. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma. J clin pathol. 2013;66(7): 613–619. doi:10.1136/jclinpath-2013-201444.
   PubMed Web of Science ®Google Scholar
• Yazdani S, Miki Y, Tamaki K, Ono K, Iwabuchi E, Abe K, Suzuki T, Sato Y, Kondo T, Sasano H. Proliferation and maturation of intratumoral blood vessels in non-small cell lung cancer. Hum pathol. 2013;44(8):1586–1596. doi:10.1016/j.humpath.2013.01.004.
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Kosaka T, Mikami S, Kikuchi E, Tanaka N, Maeda T, Ishida M, Miyajima A, Nakagawa K, Okada Y, et al. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma. Clin Cancer Res. 2012;18(15): 4145–4153. doi:10.1158/1078-0432.CCR-12-0073.
   PubMed Web of Science ®Google Scholar
• Murakami K, Kasajima A, Kawagishi N, Sekiguchi S, Fujishima F, Watanabe M, Sato Y, Ohuchi N, Sasano H. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma. Hum Pathol. 2014;45(3): 589–597. doi:10.1016/j.humpath.2013.10.028.
   PubMed Web of Science ®Google Scholar
• Xue X, Gao W, Sun B, Xu Y, Han B, Wang F, Zhang Y, Sun J, Wei J, Lu Z, et al. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene. 2013;32:1724–1734. doi:10.1038/onc.2012.177.
   PubMed Web of Science ®Google Scholar
• Kim JC, Kim KT, Park JT, Kim HJ, Sato Y, Kim HS. Expression of vasohibin-2 in pancreatic ductal adenocarcinoma promotes tumor progression and is associated with a poor clinical outcome. Hepatogastroenterology. 2015;62:251–256. doi:10.1038/onc.2012.177. PMID:25916042.
   PubMedGoogle Scholar
• Koyanagi T, Saga Y, Takahashi Y, Suzuki Y, Suzuki M, Sato Y. Downregulation of vasohibin-2, a novel angiogenesis regulator, suppresses tumor growth by inhibiting angiogenesis in endometrial cancer cells. Oncol Lett. 2013;5:1058–1062. doi:10.3892/ol.2013.1119.
   PubMed Web of Science ®Google Scholar
• Tu M, Lu C, Lv N, Wei J, Lu Z, Xi C, Chen J, Guo F, Jiang K, Li Q, et al.Vasohibin 2 promotes human luminal breast cancer angiogenesis in a non-paracrine manner via transcriptional activation of fibroblast growth factor 2.Cancer Lett. 2016;383(2):272–281. doi:10.1016/j.canlet.2016.09.031.
   PubMed Web of Science ®Google Scholar
• Xue X, Zhang Y, Zhi Q, Tu M, Xu Y, Sun J, Wei J, Lu Z, Miao Y, Gao W. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Cell Commun Signal. 2014;12(62) :1–10. doi:10.1186/s12964-014-0062-x.
   PubMed Web of Science ®Google Scholar
• Tu M, Li Z, Liu X, Lv N, Xi C, Lu Z, Wei J, Song G, Chen J, Guo F, et al. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3. Cancer Lett. 2017; 1;388:187–197. doi:10.1016/j.canlet.2016.11.016.
   PubMed Web of Science ®Google Scholar
• Tu M, Liu X, Han B, Ge Q, Li Z, Lu Z, Wei J, Song G, Cai B, Lv N, et al. Vasohibin-2 promotes proliferation in human breast cancer cells via upregulation of fibroblast growth factor-2 and growth/differentiation factor-15 expression. Mol Med Rep. 2014;10:663–669. doi:10.3892/mmr.2014.2317.
   PubMed Web of Science ®Google Scholar
• Korpal M and Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2008;5:115–119. doi:10.4161/rna.5.3.6558. PMID:19182522.
   PubMed Web of Science ®Google Scholar
• Koyanagi T, Suzuki Y, Komori K, Saga Y, Matsubara S, Fujiwara H, Sato Y. Targeting human vasohibin-2 by a neutralizing monoclonal antibody for anti-cancer treatment. Cancer Sci. 2017;108(3):512–519. doi:10.1111/cas.13149.
   PubMed Web of Science ®Google Scholar
• Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, Gnad F, Guan Y, Gilbert HN, Stinson J, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res. 2012;22(12): 2315–2327. doi:10.1101/gr.140988.112.
   PubMed Web of Science ®Google Scholar
• Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman V, Jaiswal BS, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488(7413):660–664. doi:10.1038/nature11282.
   PubMed Web of Science ®Google Scholar